John Hussman's COLL Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 105,000 shares of Collegium Pharmaceutical, Inc. (COLL) worth $3.47 M, representing 0.75% of the portfolio. First purchased in 2020-Q3, this short-term holding has been held for 6 quarters.
Based on 13F filings, John Hussman has maintained this position in COLL for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 105,000 shares. Largest reduction occurred in Q4 2020, reducing 102,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Collegium Pharmaceutical (COLL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Collegium Pharmaceutical (COLL) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +105,000 | New Buy | 105,000 | $33.07 |
| Q1 2025 | -31,500 | Sold Out | 0 | $0.00 |
| Q4 2024 | -10,500 | Reduce 25.00% | 31,500 | $28.65 |
| Q3 2024 | +42,000 | New Buy | 42,000 | $38.64 |
| Q4 2020 | -102,000 | Sold Out | 0 | $0.00 |
| Q3 2020 | +102,000 | New Buy | 102,000 | $20.82 |
John Hussman's Collegium Pharmaceutical Investment FAQs
John Hussman first purchased Collegium Pharmaceutical, Inc. (COLL) in Q3 2020, acquiring 102,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Collegium Pharmaceutical, Inc. (COLL) for 6 quarters since Q3 2020.
John Hussman's largest addition to Collegium Pharmaceutical, Inc. (COLL) was in Q1 2026, adding 105,000 shares worth $3.47 M.
According to the latest 13F filing for Q1 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 105,000 shares of Collegium Pharmaceutical, Inc. (COLL), valued at approximately $3.47 M.
As of the Q1 2026 filing, Collegium Pharmaceutical, Inc. (COLL) represents approximately 0.75% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Collegium Pharmaceutical, Inc. (COLL) was 105,000 shares, as reported at the end of Q1 2026.